文献速递肝病消化道肿瘤与早癌

慢性丙型肝炎患者进展为晚期肝病及总生存期的种族差异:持续病毒学应答的影响

Ethnic disparities in progression to advanced liver disease and overall survival in patients with chronic hepatitis C: impact of a sustained virological response.
PubMed 文献 · Aliment Pharmacol Ther · 2017-08-02

该队列研究纳入1997年1月至2016年6月在加州两个医疗中心就诊的8039例连续成人慢性丙型肝炎患者,比较不同种族之间肝硬化、肝细胞癌及总生存期的差异。结果显示西班牙裔和亚裔(而非非裔美国人)患者的肝硬化及肝细胞癌发生率显著高于白种人;获得持续病毒学应答后,西班牙裔和亚裔与白种人之间的肝病进展及总生存期种族差异消失。

要点

  • 西班牙裔和亚裔慢性丙型肝炎患者的肝硬化及肝细胞癌风险显著高于白种人,非裔美国人则无此差异。
  • 获得持续病毒学应答后,西班牙裔和亚裔患者肝硬化及肝细胞癌风险不再与白种人存在独立关联。
  • 持续病毒学应答可消除西班牙裔和亚裔与白种人之间在肝病进展及总生存期上的种族差异。

核心结论

  • 西班牙裔和亚裔与肝硬化及肝细胞癌风险升高独立相关。
  • 获得持续病毒学应答可消除西班牙裔和亚裔与白种人慢性丙型肝炎患者之间在肝病进展及总生存期上的种族差异。

研究设计与样本

  • 在加州两个医疗中心开展队列研究,纳入1997年1月至2016年6月就诊的8039例连续成人慢性丙型肝炎患者,通过逐份病历复核确认诊断。

主要发现

  • 亚裔和西班牙裔(而非非裔美国人)患者的肝硬化及肝细胞癌发生率显著高于白种人。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic hepatitis C (CHC) can lead to cirrhosis and hepatocellular carcinoma (HCC). A sustained virological response (SVR) is associated with improved outcomes, however, its impact on different ethnic groups is unknown. AIM: To evaluate ethnic differences in the natural history of CHC and the impact of SVR. METHODS: We conducted a cohort study of 8039 consecutive adult CHC patients seen at two medical centres in California between January 1997 and June 2016. Individual chart review confirmed CHC diagnosis. RESULTS: Asian and Hispanic but not African American patients had significantly higher cirrhosis and HCC incidence than Caucasians. On multivariate analysis, Hispanic ethnicity was independently associated with increased cirrhosis (adjusted HR 1.37, CI, confidence interval 1.10-1.71, P=.006) and HCC risk (adjusted HR 1.47, CI 1.13-1.92, P=.004) compared to Caucasian. Asian ethnicity had a significant association with cirrhosis (adjusted HR 1.28, CI 1.02-1.61, P=.034) and HCC risk (adjusted HR 1.29, CI 0.94-1.77, P=.025). In patients who achieved SVR, Hispanic ethnicity was no longer independently associated with cirrhosis (adjusted HR 1.76, CI 0.66-4.71, P=.26) or HCC (adjusted HR 1.05, CI 0.27-4.08, P=.94); nor was Asian ethnicity (adjusted HR 0.62, CI 0.21-1.82, P=.38 for cirrhosis; 2.01, CI 0.63-6.36, P=.24 for HCC). Similar findings were observed with overall survival among the ethnicities by SVR status. CONCLUSION: Hispanic and Asian ethnicity was independently associated with increased cirrhosis and HCC risk. Achieving an SVR eliminates the ethnic disparity in liver disease progression and overall survival between Hispanic and Asian vs Caucasian CHC patients.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Le AK, Zhao C, Hoang JK, et al. Ethnic disparities in progression to advanced liver disease and overall survival in patients with chronic hepatitis C: impact of a sustained virological response. Aliment Pharmacol Ther. 2017. PMID: 28766727. doi:10.1111/apt.14241

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。